Collegium Pharmaceutical
COLL
COLL
193 hedge funds and large institutions have $1.24B invested in Collegium Pharmaceutical in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 58 increasing their positions, 77 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
+19
Holders Change %
+10.92%
% of All Funds
2.83%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
33
Increased
58
Reduced
77
Closed
13
Calls
$305K
Puts
$2.15M
Net Calls
-$1.85M
Net Calls Change
-$790K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$61.7M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
$66.9M |
| 3 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
$9.76M |
| 4 |
Invesco
Atlanta,
Georgia
|
$44.4M |
| 5 |
Renaissance Technologies
New York
|
$42.6M |
Top Sellers
| 1 |
BlackRock
New York
|
$178M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
$84.9M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
$19.3M |
| 4 |
Marshall Wace
London,
United Kingdom
|
$4.19M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
$6.75M |
